Collision of Malignant Melanoma and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case Report and Literature Review.
- 1Pathology Department, University of South Alabama Health, Moore Building, Room 138, Mobile, AL 36617, USA.
- 2Surgical Oncology Department, University of South Alabama Health, Mobile, AL 36617, USA.
Abstract
Collision tumors are exceptionally rare. We report here a case of a cutaneous collision tumor composed of metastatic melanoma and small lymphocytic lymphoma (SLL). A 56-year-old man with a prior history of melanoma and chronic lymphocytic leukemia (CLL) presented with a new cutaneous nodule near the previous melanoma excision site on the right lower flank. Imaging identified a separate skin lesion in the right medial thigh. Histopathologic examination of both lesions revealed an infiltrative malignant melanoma in the flank and a melanoma with similar morphology in the medial thigh, adjacent to a dense, monotonous lymphoid infiltrate involving the subcutis and skeletal muscle. Immunohistochemical studies demonstrated that the melanoma cells were positive for SOX10, MART-1 and cyclin D1; the lymphoid population was positive for CD5, CD20, PAX5 and CD23, and negative for CD3, CD10 and cyclin D1. Given the known history, the combined morphologic and immunophenotypic findings support the diagnosis of a cutaneous collision tumor composed of melanoma and SLL/CLL. A review of the literature highlights the rarity of such cases and sheds light on current theories of pathogenesis, diagnostic pitfalls, and the mainstay treatment of this rare collision tumor.
Related
- Ultrasound-based deep learning radiomics with explainable machine learning for predicting benign and malignant thyroid nodules in lymphocytic thyroiditis: a multicenter study
- Current Evidence, Diagnostic Challenges, and Contemporary Management of Lymphocytic Colitis: A Case Report and Literature Review
- Endoscopic Submucosal Dissection as a Diagnostic and Minimally Invasive Therapeutic Excision Modality for Primary Anorectal Malignant Melanoma
- Malignant histiocytic neoplasm with dendritic differentiation via transdifferentiation of B-cell lymphoma
- Acute Lower Limb Arterial Occlusion Due to Malignant Lymphoma
BibTeX
@article{zhou2026collision,
title = {{Collision of Malignant Melanoma and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case Report and Literature Review.}},
author = {Jing Zhou and Leila Cruthirds and Emily Cornelius and John Harrison Howard and Kurt Knowles},
journal = {Dermatopathology (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/dermatopathology13040049},
url = {https://europepmc.org/article/MED/42924770},
note = {CC BY},
}
RIS
TY - JOUR
TI - Collision of Malignant Melanoma and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case Report and Literature Review.
AU - Jing Zhou
AU - Leila Cruthirds
AU - Emily Cornelius
AU - John Harrison Howard
AU - Kurt Knowles
PY - 2026
DA - 2026/10/15
JO - Dermatopathology (Basel, Switzerland)
DO - 10.3390/dermatopathology13040049
UR - https://europepmc.org/article/MED/42924770
AB - Collision tumors are exceptionally rare. We report here a case of a cutaneous collision tumor composed of metastatic melanoma and small lymphocytic lymphoma (SLL). A 56-year-old man with a prior history of melanoma and chronic lymphocytic leukemia (CLL) presented with a new cutaneous nodule near the previous melanoma excision site on the right lower flank. Imaging identified a separate skin lesion in the right medial thigh. Histopathologic examination of both lesions revealed an infiltrative malignant melanoma in the flank and a melanoma with similar morphology in the medial thigh, adjacent to a dense, monotonous lymphoid infiltrate involving the subcutis and skeletal muscle. Immunohistochemical studies demonstrated that the melanoma cells were positive for SOX10, MART-1 and cyclin D1; the lymphoid population was positive for CD5, CD20, PAX5 and CD23, and negative for CD3, CD10 and cyclin D1. Given the known history, the combined morphologic and immunophenotypic findings support the diagnosis of a cutaneous collision tumor composed of melanoma and SLL/CLL. A review of the literature highlights the rarity of such cases and sheds light on current theories of pathogenesis, diagnostic pitfalls, and the mainstay treatment of this rare collision tumor.
SN - 2296-3529
ER -